Pettit GR - Search Results

1

A new anti-tubulin agent containing the benzo[b]thiophene ring system.

Pinney KG, Bounds AD, Dingeman KM, Mocharla VP, Pettit GR, Bai R, Hamel E. Pinney KG, et al. Among authors: pettit gr. Bioorg Med Chem Lett. 1999 Apr 19;9(8):1081-6. doi: 10.1016/s0960-894x(99)00143-2. Bioorg Med Chem Lett. 1999. PMID: 10328289

2

Synthesis and biological evaluation of aryl azide derivatives of combretastatin A-4 as molecular probes for tubulin.

Pinney KG, Mejia MP, Villalobos VM, Rosenquist BE, Pettit GR, Verdier-Pinard P, Hamel E. Pinney KG, et al. Among authors: pettit gr. Bioorg Med Chem. 2000 Oct;8(10):2417-25. doi: 10.1016/s0968-0896(00)00176-0. Bioorg Med Chem. 2000. PMID: 11058036

3

Preparation of new anti-tubulin ligands through a dual-mode, addition-elimination reaction to a bromo-substituted alpha, beta-unsaturated sulfoxide.

Chen Z, Mocharla VP, Farmer JM, Pettit GR, Hamel E, Pinney KG. Chen Z, et al. Among authors: pettit gr. J Org Chem. 2000 Dec 15;65(25):8811-5. doi: 10.1021/jo0004761. J Org Chem. 2000. PMID: 11112609 No abstract available.

4

Antineoplastic agents. 379. Synthesis of phenstatin phosphate.

Pettit GR, Toki B, Herald DL, Verdier-Pinard P, Boyd MR, Hamel E, Pettit RK. Pettit GR, et al. Among authors: pettit rk. J Med Chem. 1998 May 7;41(10):1688-95. doi: 10.1021/jm970644q. J Med Chem. 1998. PMID: 9572894

5

Antineoplastic agents. 410. Asymmetric hydroxylation of trans-combretastatin A-4.

Pettit GR, Toki BE, Herald DL, Boyd MR, Hamel E, Pettit RK, Chapuis JC. Pettit GR, et al. Among authors: pettit rk. J Med Chem. 1999 Apr 22;42(8):1459-65. doi: 10.1021/jm9807149. J Med Chem. 1999. PMID: 10212132

6

Antineoplastic agents. 443. Synthesis of the cancer cell growth inhibitor hydroxyphenstatin and its sodium diphosphate prodrug.

Pettit GR, Grealish MP, Herald DL, Boyd MR, Hamel E, Pettit RK. Pettit GR, et al. Among authors: pettit rk. J Med Chem. 2000 Jul 13;43(14):2731-7. doi: 10.1021/jm000045a. J Med Chem. 2000. PMID: 10893310

7

Antineoplastic agents 360. Synthesis and cancer cell growth inhibitory studies of dolastatin 15 structural modifications.

Pettit GR, Flahive EJ, Boyd MR, Bai R, Hamel E, Pettit RK, Schmidt JM. Pettit GR, et al. Among authors: pettit rk. Anticancer Drug Des. 1998 Jan;13(1):47-66. Anticancer Drug Des. 1998. PMID: 9474242

8

Antineoplastic agents 365. Dolastatin 10 SAR probes.

Pettit GR, Srirangam JK, Barkoczy J, Williams MD, Boyd MR, Hamel E, Pettit RK, Hogan F, Bai R, Chapuis JC, McAllister SC, Schmidt JM. Pettit GR, et al. Among authors: pettit rk. Anticancer Drug Des. 1998 Jun;13(4):243-77. Anticancer Drug Des. 1998. PMID: 9627667

9

Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6(1a).

Pettit GR, Singh SB, Boyd MR, Hamel E, Pettit RK, Schmidt JM, Hogan F. Pettit GR, et al. Among authors: pettit rk. J Med Chem. 1995 May 12;38(10):1666-72. doi: 10.1021/jm00010a011. J Med Chem. 1995. PMID: 7752190

10

Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data.

Bai RL, Paull KD, Herald CL, Malspeis L, Pettit GR, Hamel E. Bai RL, et al. Among authors: pettit gr. J Biol Chem. 1991 Aug 25;266(24):15882-9. J Biol Chem. 1991. PMID: 1874739 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

463 results

Search Page

Filters